Modulation of tryptophan metabolism, promotion of neurogenesis and alteration of anxiety-related behavior in tryptophan 2,3-dioxygenase-deficient mice

International Journal of Tryptophan Research

Volumn 4, Issue 1, 2011, Pages 7-18

  Funakoshi, Hiroshi ^a,b,d   Kanai, Masaaki ^a,b,d   Nakamura, Toshikazu ^c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Microbiology and Immunology ^*  (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Autism; Indoleamine 2,3 dioxygenase (IDO); Knockout mice; Kynurenines; Serotonin; Tryptophan 2,3 dioxygenase (TDO)

Indexed keywords

EID: 84859739642     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.4137/IJTR.S5783     Document Type: Article

References (54)

1. Mollica RF, Cardozo BL, Osofsky HJ, Raphael B, Ager A, Salama P. Mental health in complex emergencies. Lancet. 2004;364:2058-67.
2. Erspamer V. Biological activity of some enteramine-related substances. Nature. 1952;170:281-2.
3. Walther DJ, Peter JU, Bashammakh S, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76.
4. Yamauchi T, Nakata H, Fujisawa H. A new activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+-, calmodulin-dependent protein kinase. Purification and characterization. J Biol Chem. 1981;256:5404-9.
5. Nakata H, Fujisawa H. Simple and rapid purification of tryptophan 5-monooxygenase from rabbit brain by affinity chromatography. J Biochem. 1981;90:567-9.
6. Zhang X, Gainetdinov RR, Beaulieu JM, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 2005;45:11-6.
7. Gutknecht L, Jacob C, Strobel A, et al. Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol. 2007;10:309-20.
8. Hayaishi O, Okuno S, Fujisawa H. Inhibition of brain tryptophan 5-monooxygenase by aquayamycin. Biochem Biophys Res Commun. 1970; 39:643-50.
9. Fujisawa H, Funakoshi H, Makita Y, Okuno S. Regulatory mechanisms of tyrosine and tryptophan hydroxylases by protein knases. International Symposium on Oxygenases and Oxygen activation: Yamada Science Foundation; 1991.
10. Peters JC. Tryptophan nutrition and metabolism: an overview. Adv Exp Med Biol. 1991;294:345-58.
11. Kotake Y, Masayama T. Uber den Mechanismus der Kynurenine-building aus Tryptophan. Hoppe-Seyler's Z Physiol Cehm. 1937;243:237-44.
12. Hayaishi O, Rothberg S, Mehler AH, Saito Y. Studies on oxygenases; enzymatic formation of kynurenine from tryptophan. J Biol Chem. 1957;229: 889-96.
13. Hayaishi O. My life with tryptophan-never a dull moment. Protein Sci. 1993;2:472-5.
14. Kornberg A, Hayaishi O. Pioneer first of the oxygenases, then the molecular basis of sleep and throughout a great statesman of science. IUBMB Life. 2006;58:253.
15. Hayaishi O. Memoirs of a biochemist. IUBMB Life. 2006;58:242-5.
16. Maezono K, Tashiro K, Nakamura T. Deduced primary structure of rat tryptophan-2,3-dioxygenase. Biochem Biophys Res Commun. 1990;170: 176-81.
17. Higuchi K, Hayaishi O. Enzymic formation of D-kynurenine from D-tryptophan. Arch Biochem Biophys. 1967;120:397-403.
18. Tone S, Takikawa O, Habara-Ohkubo A, Kadoya A, Yoshida R, Kido R. Primary structure of human indoleamine 2,3-dioxygenase deduced from the nucleotide sequence of its cDNA. Nucleic Acids Res. 1990;18:367.
19. Hayaishi O. Tryptophan, oxygen, and sleep. Annu Rev Biochem. 1994;63: 1-24.
20. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4:762-74.
21. Moroni F, Cozzi A, Peruginelli F, Carpenedo R, Pellegrini-Giampietro DE. Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia. Adv Exp Med Biol. 1999;467:199-206.
22. Schwarcz R. The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol. 2004;4:12-7.
23. Samsonova ML, Lapin IP. Antidepressants and liver tryptophan pyrrolase activity. Biochem Pharmacol. 1973;22:1499-507.
24. Badawy AA, Evans M. Letter: Tryptophan plus a pyrrolase inhibitor for depression? Lancet. 1974;2:1209-10.
25. Kanai M, Funakoshi H, Takahashi H, et al. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain. 2009;2:8.
26. Herve C, Beyne P, Jamault H, Delacoux E. Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B Biomed Appl. 1996;675:157-61.
27. Morita I, Kawamoto M, Hattori M, Eguchi K, Sekiba K, Yoshida H. Determination of tryptophan and its metabolites in human plasma and serum by high-performance liquid chromatography with automated sample clean-up system. J Chromatogr. 1990;526:367-74.
28. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805-9.
29. Franklin K, Paxinos G. The mouse brain in stereotaxic coordinates. Academic Press. 1997.
30. Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem. 1998;5:302-16.
31. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol. 2004;61:67-77.
32. Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry. 2006;59:1136-43.
33. Kanai M, Nakamura T, Funakoshi H. Identification and characterization of novel variants of the tryptophan 2,3-dioxygenase gene: differential regulation in the mouse nervous system during development. Neurosci Res. 2009;64:111-7.
34. Miller CL, Llenos IC, Dulay JR, Weis S. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res. 2006;1073-1074:25-37.
35. Yamasaki N, Maekawa M, Kobayashi K, et al. Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain. 2008;1:6.
36. Savvateeva E. Kynurenines in the regulation of behavior in insects. Adv Exp Med Biol. 1991;294:319-28.
37. Orlikov AB, Prakhye IB, Ryzov IV. Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression. Biol Psychiatry. 1994;36:97-102.
38. Yuwiler A, Wetterberg L, Geller E. Relationship between alternate routes of tryptophan metabolism following administration of tryptophan peroxidase inducers or stressors. J Neurochem. 1971;18:593-9.
39. Salter M, Pogson CI. The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes. Biochem J. 1985;229:499-504.
40. Knox WE, Mehler AH. The adaptive increase of the tryptophan peroxidaseoxidase system of liver. Science. 1951;113:237-8.
41. Geschwind II, Li CH. Influence of hypophysectomy and of adrenocorticotropic hormone on a mammalian adaptive enzyme system. Nature. 1953; 172:732-3.
42. Labrie F, Korner A. Effect of glucagon, insulin, and thyroxine on tyrosine transaminase and tryptophan pyrrolase of rat liver. Arch Biochem Biophys. 1969;129:75-8.
43. Sitaramam V, Ramasarma T. Inhibition of cortisol-mediated induction of hepatic tryptophan-2,3-dioxygenase by norepinephrine. Biochem Biophys Res Commun. 1974;59:578-83.
44. Nozaki M, Okuno S, Fujisawa H. The mechanism of inhibition of tryptophan 2,3-dioxygenase by aquayamycin. Biochem Biophys Res Commun. 1971;44:1109-16.
45. Berg T, Boman D, Seglen PO. Induction of tryptophan oxygenase in primary rat liver cell suspensions by glucocorticoid hormone. Exp Cell Res. 1972;72:571-4.
46. Niimi S, Nakamura T, Nawa K, Ichihara A. Hormonal regulation of translatable mRNA of tryptophan 2,3-dioxygenase in primary cultures of adult rat hepatocytes. J Biochem. 1983;94:1697-706.
47. Nakamura T, Shinno H, Ichihara A. Insulin and glucagon as a new regulator system for tryptophan oxygenase activity demonstrated in primary cultured rat hepatocytes. J Biol Chem. 1980;255:7533-5.
48. Nakamura T, Aoyama K, Tomomura A, Ichihara A. Hormonal control of the development of tryptophan oxygenase in primary cultures of young rat hepatocytes. Biochim Biophys Acta. 1981;678:91-7.
49. Nakamura T, Niimi S, Nawa K, et al. Multihormonal regulation of transcription of the tryptophan 2,3-dioxygenase gene in primary cultures of adult rat hepatocytes with special reference to the presence of a transcriptional protein mediating the action of glucocorticoids. J Biol Chem. 1987;262:727-33.
50. Nomura J. Effects of stress and psychotropic drugs on rat liver tryptophan pyrrolase. Endocrinology. 1965;76:1190-4.
51. Comings DE. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann N Y Acad Sci. 2001;931: 50-83.
52. Comings DE, Gade R, Muhleman D, et al. Exon and intron variants in the human tryptophan 2,3-dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders. Pharmacogenetics. 1996;6: 307-18.
53. Nabi R, Serajee FJ, Chugani DC, Zhong H, Huq AH. Association of tryptophan 2,3 dioxygenase gene polymorphism with autism. Am J Med Genet B Neuropsychiatr Genet. 2004;125B:63-8.
54. Guillemin GJ, Cullen KM, Lim CK, et al. Characterization of the kynurenine pathway in human neurons. J Neurosci. 2007;27:12884-92.